International Journal of Thyroidology

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2466-1899   pISSN 2384-3799

Table. 6.

Table. 6.

Clinical outcomes of CEA-negative patients at detection of recurrence

Age Sex T stage Size
(cm)
mLN
(Number)
N
stage
Metastasis
(site)
Calcitonin
(pg/mL)
CEA
(ng/mL)
Clinical outcome
Patients with local recurrence
30 F 3a 4.0 10 1b LN 185 1.3 Recura
50 M 1a 1.6 2 1a LN 399 2.4 Death
58 M 1b 1.4 3 1a LN 312 0.5 Recur
49 F 3b 1.5 11 1b LN 162 0.5 Recur
52 M 1b 0.9 2 1b LN 66 2.8 Recurb
47 F 2 2.6 3 1a LN 51 1.2 Deathc
51 M 1a 1.0 3 1a LN 131 2.0 Recur
21 M 1a 0.6 7 1a LN 159 3.0 Recur
37 F 1b 1.5 24 1b LN 549 0.7 Recur
57 F 1a 1.2 1 1a LN 78 2.4 Recur
42 F 3a 5.6 14 1b LN 4542 4.2 Recur
Patients with distant recurrence
30 F 3a 4.0 10 1b Lung 401 3.4 Recura
52 M 1a 0.9 2 1b Lung 770 3.8 Recurb
47 F 2 2.6 3 1a Bone 3320 1.1 Deathc
72 M 3a 6.5 46 1b Liver 14826 3.6 Death

CEA: carcinoembryonic antigen, LN: lymph node, mLN: metastatic lymph node

a,b,cResults observed for the clinical course of the same patient are indicated by the same letter.

Int J Thyroidol 2021;14:143-51 https://doi.org/10.11106/ijt.2021.14.2.143
© 2021 Int J Thyroidol